NORADRENALINE (NOREPINEPHRINE) 0.1 Mg/Ml Irland - engelsk - HPRA (Health Products Regulatory Authority)

noradrenaline (norepinephrine) 0.1 mg/ml

martindale pharmaceuticals ltd - noradrenaline acid tartrate - 0.1 mg/ml

ADRENALINE AUTO INJECT SUN 300 adrenaline (epinephrine) 300 microgram/0.3mL solution for injection auto-injector syringe Australia - engelsk - Department of Health (Therapeutic Goods Administration)

adrenaline auto inject sun 300 adrenaline (epinephrine) 300 microgram/0.3ml solution for injection auto-injector syringe

sun pharma anz pty ltd - adrenaline (epinephrine), quantity: 0.3 mg - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium metabisulfite; hydrochloric acid - for the emergency treatment of anaphylaxis (acute severe allergic reactions) due to insect stings, or bites, foods, drugs or other allergens.

ADRENALINE AUTO INJECT JR SUN 150 adrenaline (epinephrine) 150 microgram/0.3mL solution for injection auto-injector syringe Australia - engelsk - Department of Health (Therapeutic Goods Administration)

adrenaline auto inject jr sun 150 adrenaline (epinephrine) 150 microgram/0.3ml solution for injection auto-injector syringe

sun pharma anz pty ltd - adrenaline (epinephrine), quantity: 0.15 mg - injection, solution - excipient ingredients: sodium chloride; sodium metabisulfite; hydrochloric acid; water for injections - for the emergency treatment of anaphylaxis (acute severe allergic reactions) due to insect stings, or bites, foods, drugs or other allergens.

Bupivacaine 25mg/10ml (0.25%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

bupivacaine 25mg/10ml (0.25%) / adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules

0.25%) / adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules (advanz pharma - bupivacaine hydrochloride; adrenaline acid tartrate - solution for injection - 2.5mg/1ml ; 5microgram/1ml

Bupivacaine 50mg/10ml (0.5%) / Adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

bupivacaine 50mg/10ml (0.5%) / adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules

0.5%) / adrenaline (base) 50micrograms/10ml (1 in 200,000) solution for injection ampoules (advanz pharma - bupivacaine hydrochloride; adrenaline acid tartrate - solution for injection - 5mg/1ml ; 5microgram/1ml

2% XYLOCAINE DENTAL WITH ADRENALINE 1:80,000 2.2mL injection cartridge Australia - engelsk - Department of Health (Therapeutic Goods Administration)

2% xylocaine dental with adrenaline 1:80,000 2.2ml injection cartridge

dentsply sirona pty ltd - adrenaline (epinephrine) acid tartrate, quantity: 22.7 microgram/ml (equivalent: adrenaline (epinephrine), qty 12.5 microgram/ml); lidocaine hydrochloride monohydrate, quantity: 21.3 mg/ml (equivalent: lidocaine hydrochloride, qty 20 mg/ml) - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections; sodium metabisulfite; sodium hydroxide - indications as at 25 july 2003 : lidocaine (lignocaine) solutions are indicated for the production of local anaesthesia in routine dental procedures and oral surgery by means of infiltration and nerve block techniques. lidocaine (lignocaine) solutions with adrenaline (epinephrine) are recommended for oral surgery requiring prolonged duration of anaesthesia and haemostasis.

NORADRENALINE AGUETTANT 1MGML CONCENTRATE FOR SOLUTION FOR INFUSION Singapore - engelsk - HSA (Health Sciences Authority)

noradrenaline aguettant 1mgml concentrate for solution for infusion

aguettant asia pacific pte. ltd. - noradrenaline tartrate 2mg/ml equiv. noradrenaline - infusion, solution concentrate - noradrenaline tartrate 2mg/ml equiv. noradrenaline 1mg/ml

Xylocaine 2% with Adrenaline 1:80,000 New Zealand - engelsk - Medsafe (Medicines Safety Authority)

xylocaine 2% with adrenaline 1:80,000

astrazeneca limited - adrenaline acid tartrate 0.0227 mg/ml equivalent to 12.5 µg/ml adrenaline; lidocaine hydrochloride 20 mg/ml;  ;   - solution for injection - active: adrenaline acid tartrate 0.0227 mg/ml equivalent to 12.5 µg/ml adrenaline lidocaine hydrochloride 20 mg/ml     excipient: hydrochloric acid as 2m solution for ph adjustment (ph 3.3-5.0) methyl hydroxybenzoate sodium chloride sodium hydroxide as 2m solution for ph adjustment (ph 3.3-5.0) sodium metabisulfite water for injection